U.S. health regulators have cleared the use of Novavax Inc.’s COVID-19 vaccine, providing a new option that works differently from the two major vaccines, but at a time when overall demand for vaccines and boosters is low.
The Food and Drug Administration has said that adults 18 and older can receive the Novavax vaccine.
